John Arthur Taylor, Shreyas Joshi, Raj Satkunasivam, Rian J. Dickstein, Amirali Salmasi, Yair Lotan, Scott Johnson, Raj Pruthi, Christine Tosone, Anne K. Schuckman, Jen-Jane Liu. "Preliminary results from LEGEND: A phase 2 study of detalimogene voraplasmid (EG-70), a novel, non-viral intravesical gene therapy for patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.802